TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations
Mateo, J Porta, N McGovern, UB Jones, RJ Syndikus, I Ralph, C Jain, S Varughese, MA Parikh, O
Mateo, J
Porta, N
McGovern, UB
Jones, RJ
Syndikus, I
Ralph, C
Jain, S
Varughese, MA
Parikh, O
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Mateo J, Porta N, McGovern UB, Elliott T, Jones RJ, Syndikus I, et al. TOPARP-B: A phase II randomized trial of the poly(ADP)-ribose polymerase (PARP) inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations. J Clin Oncol. 2019;37(15_suppl):5005-.